The combined companies will operate under the name Kalaris Therapeutics, Inc. and expects to report initial data from part 1 ...

Intraoperative floppy iris syndrome is associated with an increased rate of severe intraoperative complications and greater ...

A retrospective study showed that the gender of the ophthalmologist influenced the amount of communication with the patient, ...

The bio-interventional platform is for uveoscleral outflow enhancement in open-angle glaucoma patients undergoing combined ...

After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will ...

The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed ...

CEO Stephen McLeod, MD, outlines the American Academy of Ophthalmology's commitment to advocating for evidence-based, sustainable, and equitable reforms that prioritize public health and access to ...

Formosa Pharmaceuticals and Cipla Limited have entered into an exclusive licensing agreement for the commercialization of ...

The treatment was approved by China’s National Medical Products Administration (NMPA) and is China's first, and the world’s ...

The Perimeter B-Series OCT system combines proprietary AI technology with optical coherence tomography, for use during breast ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

The Association for Research in Vision and Ophthalmology (ARVO) Foundation has announced Maria Vittoria Cicinelli, MD, Denise ...